0001127602-15-004139.txt : 20150203
0001127602-15-004139.hdr.sgml : 20150203
20150203190727
ACCESSION NUMBER: 0001127602-15-004139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150130
FILED AS OF DATE: 20150203
DATE AS OF CHANGE: 20150203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meline David W
CENTRAL INDEX KEY: 0001444612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12477
FILM NUMBER: 15572936
MAIL ADDRESS:
STREET 1: 3M COMPANY
STREET 2: 3M OFFICE OF GENERAL COUNSEL
CITY: ST PAUL
STATE: MN
ZIP: 55144-1000
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-01-30
0000318154
AMGEN INC
AMGN
0001444612
Meline David W
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
EVP & CFO
Common Stock
2015-01-30
4
A
0
3940
0
A
58537
D
These Restricted Stock Units (RSUs) were granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively.
These shares include the following RSUs granted under the Company's equity plans: 54,161 RSUs which vest in three equal installments of 13,540 on 8/1/2015, 8/1/2016 and 8/1/2017 and one installment of 13,541 on 8/1/2018; and 3,940 RSUs whicdh vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1/340 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 436 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Andrea A. Robinson, Attorney-in-Fact for Mr. Meline
2015-02-03